Document is current
Any future updates will be listed below
-
Authors
Kraft, Katerina
Murphy, Sedona E. https://orcid.org/0000-0001-8345-1955
Jones, Matthew G.
Shi, Quanming
Bhargava-Shah, Aarohi
Luong, Christy
Hung, King L. https://orcid.org/0000-0002-3662-4662
He, Britney J. https://orcid.org/0000-0001-8989-1521
Li, Rui
Park, Seung Kuk https://orcid.org/0000-0003-3795-1347
Montgomery, Michael T. https://orcid.org/0000-0002-6748-2329
Weiser, Natasha E. https://orcid.org/0000-0001-9971-2961
Wang, Yanbo
Luebeck, Jens https://orcid.org/0000-0003-4391-979X
Bafna, Vineet https://orcid.org/0000-0002-5810-6241
Boeke, Jef D. https://orcid.org/0000-0001-5322-4946
Mischel, Paul S. https://orcid.org/0000-0002-4560-2211
Boettiger, Alistair N.
Chang, Howard Y. https://orcid.org/0000-0002-9459-4393
- License Information
-
More Information
Article History
Received: 11 September 2024
Accepted: 12 September 2025
First Online: 21 October 2025
Competing interests
: H.Y.C. is a cofounder of Accent Therapeutics, Boundless Bio, Cartography Biosciences and Orbital Therapeutics; he was an advisor of 10x Genomics, Arsenal Biosciences, Chroma Medicine and Spring Discovery until 15 December 2024. H.Y.C. is an employee and stockholder of Amgen as of 16 December 2024. M.G.J. is a consultant and holds equity in Tahoe Therapeutics. P.S.M. is a co-founder and advisor of Boundless Bio. J.D.B. is a founder and director of CDI Labs, Inc.; a founder of and consultant to Opentrons LabWorks/Neochromosome, Inc.; and serves or served on the scientific advisory boards of the following: CZ Biohub New York, LLC; Logomix, Inc.; Modern Meadow, Inc.; Rome Therapeutics, Inc.; Sangamo, Inc.; Tessera Therapeutics, Inc.; and the Wyss Institute. V.B. is a cofounder, serves on the scientific advisory board of Boundless Bio and Abterra and holds equity in both companies. Q.S. is an employee and stockholder of Amgen as of 20 February 2025. K.K. is an employee and stockholder of Amgen as of 15 September 2025. The other authors declare no competing interests.
